Danaher Corp (NYSE:DHR)

205.78
Delayed Data
As of 4:00pm ET
 -0.53 / -0.26%
Today’s Change
119.60
Today|||52-Week Range
210.58
+34.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$146.4B

Company Description

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Contact Information

Danaher Corp.
2200 Pennsylvania Avenue NW
Washington District Of Columbia 20037-1701
P:(202) 828-0850
Investor Relations:

Employees

Shareholders

Mutual fund holders44.85%
Other institutional35.92%
Individual stakeholders19.00%

Top Executives

Thomas Patrick JoycePresident, Chief Executive Officer & Director
Matthew R. McGrewChief Financial Officer & Executive Vice President
Brian W. EllisChief Compliance Officer, SVP & General Counsel
Daniel L. ComasExecutive Vice President
Joakim WeidemanisExecutive Vice President